Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
38 hedge funds and large institutions have $44.2M invested in Chembio diagnostics, Inc. in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 7 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
19% more capital invested
Capital invested by funds: $37.3M → $44.2M (+$6.91M)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
3% less funds holding
Funds holding: 39 → 38 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
Roubaix Capital
Denver,
Colorado
|
+$1.1M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.04M |
| 3 |
BlackRock
New York
|
+$956K |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$607K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$291K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$527K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$247K |
| 3 |
Renaissance Technologies
New York
|
-$241K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$198K |
| 5 |
SIM
Spark Investment Management
New York
|
-$147K |
CEMI Hedge Fund Activity: Q2 2019 in Review
38 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q2 2019, worth a combined $44.2M — up 19% from $37.3M a quarter earlier.
Fund positioning in CEMI was balanced in Q2 2019: 7 funds opened new positions, 7 closed out, 10 added to existing stakes and 8 trimmed.
The largest buyer was Roubaix Capital, opening a new position worth an estimated $1.1M. The largest seller was Millrace Asset Group, cutting an estimated $527K.
- 38 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q2 2019, down from 39 in Q1 2019.
- Funds reported $44.2M of Chembio diagnostics, Inc. stock for Q2 2019, up 19% quarter-over-quarter.
- 7 funds opened new Chembio diagnostics, Inc. positions in Q2 2019 and 7 closed out, a net change of 0 holders.
- The largest Chembio diagnostics, Inc. buyer in Q2 2019 was Roubaix Capital, an estimated $1.1M added.
- The largest Chembio diagnostics, Inc. seller in Q2 2019 was Millrace Asset Group, an estimated $527K sold.
Based on aggregated 13F filings for Q2 2019.